Asia's Ascent — Global Trends in Biomedical R&D Expenditures
2014
In recent years, industry has reduced its investment in U.S. biomedical research and development by billions of dollars, while increasing investment in Asia–Oceania. Thus, boosting U.S. government funding alone may be inadequate for retaining long-term R&D leadership.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
4
References
102
Citations
NaN
KQI